Sanofi-aventis, formed in 2004 following the acquisition of Aventis by Sanofi-Synthelabo, is a leading global pharmaceutical company engaged in the research, development, manufacture, and marketing of healthcare products. As the third-largest pharmaceutical maker in the world, their extensive research and development efforts address key health care challenges in cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. Sanofi-aventis is dedicated to improving health and driving back disease by making innovative medicines accessible to people around the world.
Sanofi-aventis is headquartered in Paris, France and employs nearly 100,000 people in over 100 counties. Its U.S. headquarters is located in Bridgewater, NJ and is responsible for employing over 15,000 people across the county. Sanofi-aventis trades on the NYSE: SNY and Euronext: SAN and has an annual revenue of approximately $32 billion.
No comments:
Post a Comment